Cantor Fitzgerald Reaffirms Their Buy Rating on Cigna (CI)
Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Cigna (CI – Research Report) yesterday and set a price target of $350.00. The ...
Cantor Fitzgerald cuts Teradyne stock target to $150, keeps rating
Cantor Fitzgerald adjusted its price target for Teradyne stock (NASDAQ:TER), bringing it down to $150 from the previous $160, while still maintaining an Overweight rating on the company's shares.
Fintel on MSN14h
Cantor Fitzgerald Upgrades Lam Research (LRCX)
Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (NasdaqGS:LRCX) from ...
Cantor Fitzgerald Suit Against Ex-Bankers’ Firm Is Dismissed
Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.